Log in or Sign up for Free to view tailored content for your specialty!
Mood Disorders News
Mood stabilizers lower risk for mania following methylphenidate treatment in bipolar disorder
Risk for mania following methylphenidate treatment was significantly lower among individuals with bipolar disorder who received mood stabilizers concomitantly, according to recent findings.
Beta-blockers, calcium channel blockers linked to higher risk for mood disorders
Certain common antihypertension medications affect mood disorders such as major depression and bipolar disorder, according to findings published in Hypertension.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves sNDA for Adasuve for agitation in schizophrenia, bipolar I disorder
The FDA recently approved a supplemental New Drug Application for changes to the product label and Risk Evaluation Mitigation Strategy Program for Adasuve, an inhalation powder for acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
Group psychoeducation comparable to peer support for remitted bipolar disorder
Structured group psychoeducation was no more effective than unstructured peer support for remitted bipolar disorder, though was more beneficial to individuals with fewer past bipolar episodes.
Top 5 depression articles for psychiatrists
In 2014, approximately 15.7 million adults, or 6.7% of all U.S. adults, experienced at least one major depressive episode in the past year, according to data from the National Survey on Drug Use and Health.
Inflammation may be associated with broader range of psychological distress
Levels of high-sensitivity C-reactive protein was associated with 18 general symptoms of psychological distress, and most associations remained positive after adjusting for smoking, alcohol consumption, body mass index, and chronic illnesses.
Top 5 studies from 2016 ECNP Congress
The European College of Neuropsychopharmacology Congress, which took place from September 17 to 20 in Vienna, featured presentations, posters, abstracts and addresses on a broad range of topics associated with psychiatry, neurology, psychology, pharmacology and pediatrics.
Secondary data indicate further efficacy of SAGE-547 for postpartum depression
Sage Therapeutics announced positive findings for secondary endpoints of a phase 2 clinical trial assessing safety and efficacy of SAGE-547, an IV treatment for postpartum depression, among women who developed severe depression during or following childbirth.
Study suggests neural differences may affect attention in MDD
Recent findings showed altered norepinephrine transmission among individuals with major depressive disorder, suggesting the alteration could be associated with attention in this disorder.
Top 5 articles for psychiatrists who treat children, adolescents
Study findings have indicated that half of all lifetime mental illness begin by age 14 years, according to the NIMH.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read